[Role of 13C-methacetin breath test in patients with chronic diffuse liver disease].
The paper is concerned with the problem of incidence and prevalence of chronic liver disease. The methodology is described of conducting a 13C-methacetin breath test to assess hepatic insufficiency. Sensitivity and specificity, advantages of this non-invasive test are shown together with its merits and prospects for a wide use in gastroenterology.
Mikhn'ova
N M
NM
Shypulin
V P
VP
D000081:Acetamides; D001944:Breath Tests / Q000379:methods; D002245:Carbon Dioxide / Q000378:metabolism*; D002247:Carbon Isotopes; D002908:Chronic Disease; D005260:Female; D006506:Hepatitis A / Q000175:diagnosis / Q000378:metabolism; D006509:Hepatitis B / Q000175:diagnosis / Q000378:metabolism; D006526:Hepatitis C / Q000175:diagnosis / Q000378:metabolism; D022781:Hepatocytes / Q000378:metabolism; D006801:Humans; D015994:Incidence; D008107:Liver Diseases / Q000175:diagnosis* / Q000378:metabolism; D008297:Male; D015995:Prevalence; D012680:Sensitivity and Specificity; D012720:Severity of Illness Index
D000081:Acetamides; D002247:Carbon Isotopes; C035495:methacetin; D002245:Carbon Dioxide